DocGo Inc.
Datakwaliteit: 100%
DCGO
NASDAQ
Services
Health Services
€ 0,52
▼
€ 0,06
(-9,85%)
Marktkapitalisatie: 51,33 M
Prijs
€ 0,52
Marktkapitalisatie
51,33 M
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—
Quick Summary
Belangrijkste Punten
Revenue grew 0,27% annually over 5 years — modest growth
Earnings declined -1465,21% over the past year
Debt/Equity of 0,00 — conservative balance sheet
Generating 29,91 M in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 48,01%
Capital efficient — spends only 1,41% of revenue on capex
Groei
Revenue Growth (5Y)
0,27%
Onder sectorgemiddelde (3,99%)
Revenue (1Y)-47,74%
Earnings (1Y)-1465,21%
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-64,25%
Onder sectorgemiddelde (-15,95%)
ROIC-47,81%
Net Margin-56,61%
Op. Margin-55,26%
Veiligheid
Debt / Equity
0,00
Onder sectorgemiddelde (0,39)
Current Ratio2,59
Interest CoverageN/A
Waardering
PE (TTM|NTM|2027)
-0,28 | 0,81 | 0,81
Boven sectorgemiddelde (-1,17)
P/B Ratio0,19
EV/EBITDAN/A
Dividend YieldN/A
Koershistorie
Financiële Trends
Sectorvergelijking
vs Services sector mediaan (515 peers)
Sectorvergelijking
vs Services sector mediaan (515 peers)| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -0,3 | -1,2 |
| P/B | 0,2 | 1,4 |
| ROE % | -64,3 | -16,0 |
| Net Margin % | -56,6 | -18,3 |
| Rev Growth 5Y % | 0,3 | 4,0 |
| D/E | 0,0 | 0,4 |
Koersdoel Analisten
5 analisten
Buy
Huidig
€ 0,52
Koersdoel
€ 2,10
€ 1,00
€ 2,50
€ 3,00
Vooruitzicht
Forward K/W
0,81
Forward WPA
€ 0,64
WPA Groei (sch.)
+413,6%
Omzet Sch.
319,10 M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2027 |
€ 0,64
€ 0,04 – € 1,25
|
319,10 M | 2 |
| FY2026 |
€ 0,13
-€ 0,44 – € 0,69
|
298,91 M | 2 |
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| 2026 Q2 |
-€ 0,01
-€ 0,15 – € 0,13
|
73,04 M | 2 |
| 2026 Q1 |
-€ 0,06
-€ 0,22 – € 0,10
|
72,43 M | 2 |
Winstverassingen
Laatste 4 kwartalen
| Kwartaal | Geschat WPA | Werkelijk WPA | Verrassing |
|---|---|---|---|
| Q42025 | -€ 0,34 | -€ 1,68 | -390,0% |
| Q32025 | -€ 0,40 | -€ 0,25 | +38,5% |
| Q22025 | -€ 0,23 | -€ 0,21 | +7,1% |
| Q12025 | € 0,03 | -€ 0,17 | -622,1% |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -47,74% | Revenue Growth (3Y) | -28,16% |
| Earnings Growth (1Y) | -1465,21% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 0,27% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 322,20 M | Net Income (TTM) | -182,40 M |
| ROE | -64,25% | ROA | -47,87% |
| Gross Margin | N/A | Operating Margin | -55,26% |
| Net Margin | -56,61% | Free Cash Flow (TTM) | 29,91 M |
| ROIC | -47,81% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,00 | Current Ratio | 2,59 |
| Interest Coverage | N/A | Asset Turnover | 0,85 |
| Working Capital | 116,64 M | Tangible Book Value | 211,50 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -0,28 | Forward P/E | 0,81 |
| P/B Ratio | 0,19 | P/S Ratio | 0,16 |
| PEG Ratio | N/A | Forward PEG | 0,00 |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 0,16 | Fwd Earnings Yield | 123,46% |
| FCF Yield | 58,26% | ||
| Market Cap | 51,33 M | Enterprise Value | -21,78 M |
| Per Share | |||
| EPS (Diluted TTM) | -1,84 | Revenue / Share | 3,26 |
| FCF / Share | 0,30 | OCF / Share | 0,35 |
| EPS CAGR (1Y) | -1122,22% | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | 1,41% | FCF Conversion | -16,40% |
| SBC-Adj. FCF | 12,45 M | Growth Momentum | -48,01 |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 322,20 M | 616,56 M | 624,29 M | 440,52 M | — |
| Net Income | -182,40 M | 13,36 M | 10,05 M | 34,58 M | -148.751,0 |
| EPS (Diluted) | -1,84 | 0,18 | 0,06 | 0,34 | — |
| Gross Profit | — | — | — | — | — |
| Operating Income | -178,03 M | 28,69 M | 15,05 M | 21,83 M | -168.830,0 |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 13,56 M | 11,59 M | 10,86 M | 5,38 M | — |
| SG&A Expenses | — | — | — | — | — |
| D&A | 15,66 M | 15,88 M | 4,83 M | 10,57 M | — |
| Interest Expense | — | — | 1,68 M | 117.664,0 | — |
| Income Tax | 8,87 M | 14,39 M | 6,36 M | -7,96 M | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 217,10 M | 455,62 M | 490,45 M | 393,28 M | 116,07 M |
| Total Liabilities | 91,23 M | 140,44 M | 185,28 M | 114,35 M | 4,18 M |
| Shareholders' Equity | 144,01 M | 320,92 M | 300,79 M | 273,23 M | 5,00 M |
| Total Debt | 235.583,0 | 17.730,0 | 69.717,0 | — | — |
| Cash & Equivalents | 51,02 M | 89,24 M | 59,29 M | 157,34 M | 878.653,0 |
| Current Assets | 152,40 M | 304,49 M | 338,87 M | 271,08 M | 1,05 M |
| Current Liabilities | 67,49 M | 121,81 M | 170,12 M | 100,16 M | 159.850,0 |
Strategiescores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#145 of 172
Recente Activiteit
Ingestapt
Deep Value Investing (Seth Klarman)
Apr 12, 2026
{"event":"ticker_viewed","properties":{"ticker":"DCGO","listing_kind":"stock","pathname":"/stocks/dcgo","exchange":"NASDAQ","country":"US"}}




